More Than Just Risk: Genetic Testing Is Shaping Breast Cancer Treatment

https://investor.myriad.com/news-releases/news-release-detail/?newsItemId...

News Release - Investor relations - Myriad Genetics

Aug 25, 2022 ... BRACAnalysis Diagnostic System is designed to detect and interpret germline BRCA1 and BRCA2 variants. The test identifies deleterious or ...

https://myriad.com/myriad.../what-are-the-guidelines-for-surveillance-for-a/

Guidelines for BRCA-positive patient after surgery - Myriad Genetics

Jan 11, 2013 ... Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol. 2004 ...

https://investor.myriad.com/news-releases/news-release-detail/11851/

Myriad Significantly Advances the myChoice(R) HRD(TM ...

May 29, 2015 ... ... BRCA1/2 and other homologous recombination genes and who have a ... BRCA1/2 mutation-associated breast cancer. The endpoints of this ...

https://investor.myriad.com/news-releases/news-release-detail/11611/

News Release - Investor relations - Myriad Genetics

Sep 10, 2007 ... "The risks of breast and ovarian cancers are very high in individuals carrying mutations in either the BRCA1 or BRCA2 genes. Through a blood ...

https://investor.myriad.com/news-releases/news-release-detail/21111/

Myriad Seeks Japanese Regulatory Approval for its BRACAnalysis ...

Mar 30, 2020 ... ... BRCA1 and BRCA2 mutations and may be candidates for targeted therapy with the PARP inhibitor, Lynparza^® (olaparib), subject to regulatory ...

https://myriad.com/genetic-tests/mychoicecdx-tumor-test/

MyChoice® CDx HRD Companion Diagnostic Test - Myriad Genetics

Tumor BRCA1/BRCA2 status; Interpretation of any tumor BRCA1 and BRCA2 variants identified; Overall test interpretation most relevant to patient management (if ...

https://investor.myriad.com/news-releases/news-release-detail/21781/

Myriad Genetics Receives Reimbursement for BRACAnalysis ...

... BRCA1 and BRCA2 mutations to receive regulatory approval in Japan. “Now that BRACAnalysis is available in Japan to assess the presence of BRCA1 or BRCA2 in ...

https://investor.myriad.com/news-releases/news-release-detail/11736/

Myriad Receives FDA Approval of BRACAnalysis CDx(TM) as ...

Dec 19, 2014 ... Lynparza is the first poly ADP-ribose polymerase (PARP) inhibitor for patients with germline mutations in BRCA1/2 advanced ovarian cancer ...

https://investor.myriad.com/news-releases/news-release-detail/22906/

Myriad Genetics Receives FDA Approval of BRACAnalysis® CDx as ...

Mar 11, 2022 ... More patients with breast cancer now potentially qualify for BRCA testing.” BRACAnalysis CDx is intended to detect and interpret germline BRCA1 ...

https://myriad.com/education/videos/

Videos | Myriad Genetics

I need help with… Understanding hereditary cancer riskWhat is my risk of developing hereditary cancer? Treating cancerWhat are my treatment options?